# Prognostic Value of Neonatal Markers for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus in Utero

> **NCT01923636** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 254 (actual)

## Conditions studied

- Congenital Cytomegalovirus Infection

## Interventions

- **OTHER:** detection of CMV

## Key facts

- **NCT ID:** NCT01923636
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-09
- **Primary completion:** 2021-01-30
- **Final completion:** 2022-05-16
- **Target enrollment:** 254 (ACTUAL)
- **Last updated:** 2025-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01923636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01923636, "Prognostic Value of Neonatal Markers for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus in Utero". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01923636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*